Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer

NCT00058006 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Lung Cancer

Interventions

DRUG: celecoxib
PROCEDURE: adjuvant therapy

Sponsor

Northwestern University

Collaborators

[object Object]